Penn Mutual Asset Management, LLC Organon & Co. Transaction History

Penn Mutual Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$17.45 - $21.96 $43,625 - $54,900	-2,500 Reduced 10.57%	21,150 $437,000
Q1 2024 May 15, 2024	SELL	$13.78 - $18.8 $1.49 Million - $2.04 Million	-108,350 Reduced 82.08%	23,650 $444,000
Q4 2023 Feb 13, 2024	BUY	$10.95 - $17.32 $1 Million - $1.58 Million	91,500 Added 225.93%	132,000 $1.9 Million
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $671,895 - $962,685	40,500 New	40,500 $703,000

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Penn Mutual Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Penn Mutual Asset Management, LLC with notifications on news.